The invention relates to pharmaceutical formulations and methods for preparing
pharmaceutical formulations of histamine releasers. The present invention provides
methods for determining the concentration of physiologically acceptable excipients
for use in the formulations of the invention. The present invention also provides
methods for suppressing pharmaceutically-induced histamine release by administering
to an animal, the formulations of the present invention. A kit useful for preparing
pharmaceutical formulations of histamine releasers is also provided.
